InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: None

Wednesday, 02/06/2013 4:47:02 PM

Wednesday, February 06, 2013 4:47:02 PM

Post# of 1901
CLDX - Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma

http://clinicaltrials.gov/ct2/show/NCT01480479?term=Celldex+Therapeutics%2C+Inc.&rank=4

Estimated Enrollment: 440
Study Start Date: November 2011
Estimated Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)





GLTA... KarinCA ;)

"Be kinder than necessary, for everyone you meet is fighting some kind of battle."



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CLDX News